{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T14:02:13Z","timestamp":1785852133865,"version":"3.56.0"},"reference-count":12,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"7","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clin Nucl Med"],"published-print":{"date-parts":[[2019,7]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    <jats:sup>18<\/jats:sup>\n                    F-fluorocholine (\n                    <jats:sup>18<\/jats:sup>\n                    F-FCH) PET\/CT is widely used to study patients affected by prostate cancer. Despite its specificity, however,\n                    <jats:sup>18<\/jats:sup>\n                    F-FCH may be taken up by other neoplasms such as multiple myeloma, lymphomas, lung, bladder, and colon cancer; brain tumors; and renal and hepatocellular carcinoma. This is due to its ability to evaluate the cell proliferation, which is typical of neoplastic cells. While this behavior may be an opportunity to image more neoplasms, on the other hand it could represent a source of error in the evaluation of the images. Here we present the case of a laryngeal squamous cell carcinoma detected by\n                    <jats:sup>18<\/jats:sup>\n                    F-FCH.\n                  <\/jats:p>","DOI":"10.1097\/rlu.0000000000002596","type":"journal-article","created":{"date-parts":[[2019,5,6]],"date-time":"2019-05-06T16:38:09Z","timestamp":1557160689000},"page":"e435-e438","source":"Crossref","is-referenced-by-count":1,"title":["Early-Stage Supraglottic \u201cIn Situ\u201d Squamous Cell Carcinoma of the Larynx Incidentally Detected by 18F-Fluorocholine PET\/CT"],"prefix":"10.1097","volume":"44","author":[{"given":"Stefano Attilio","family":"Mangili","sequence":"first","affiliation":[{"name":"Sant'Anna Hospital;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicola","family":"Rizzardi","sequence":"additional","affiliation":[{"name":"ATS; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonia","family":"Illuminati","sequence":"additional","affiliation":[{"name":"Poliambulanza Hospital, Brescia, Italy."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudio","family":"Bn\u00e0","sequence":"additional","affiliation":[{"name":"Poliambulanza Hospital, Brescia, Italy."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giordano","family":"Savelli","sequence":"additional","affiliation":[{"name":"Poliambulanza Hospital, Brescia, Italy."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2019,5,3]]},"reference":[{"key":"bib1-20230925","doi-asserted-by":"crossref","first-page":"1995","DOI":"10.1007\/s00259-016-3392-7","article-title":"18F-fluorocholine versus 18F-fluorodeoxyglucose for PET\/CT imaging in patients with suspected relapsing or progressive multiple myeloma: a pilot study","volume":"43","year":"2016","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"bib2-20230925","doi-asserted-by":"crossref","first-page":"e471","DOI":"10.1097\/RLU.0000000000002296","article-title":"18F-choline and 18F-FDG PET\/CT in a patient with diffuse large B-cell lymphoma and recurrent prostate cancer","volume":"43","year":"2018","journal-title":"Clin Nucl Med"},{"key":"bib3-20230925","first-page":"746","article-title":"Incidental detection of a Hodgkin lymphoma on 18F-choline PET\/CT and comparison with 18FDG PET\/CT in a patient with prostate cancer: reply","volume":"41","year":"2016","journal-title":"Clin Nucl Med"},{"key":"bib4-20230925","doi-asserted-by":"crossref","first-page":"1826","DOI":"10.1097\/JTO.0000000000000270","article-title":"Resection of a solitary pulmonary metastasis from prostatic adenocarcinoma misdiagnosed as a bronchocele: usefulness of 18F-choline and 18F-FDG PET\/CT","volume":"9","year":"2014","journal-title":"J Thorac Oncol"},{"key":"bib5-20230925","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1097\/RLU.0000000000001754","article-title":"Incidental papillary bladder carcinoma on 18F-fluoromethylcholine PET\/CT undertaken to evaluate prostate malignancy","volume":"42","year":"2017","journal-title":"Clin Nucl Med"},{"key":"bib6-20230925","first-page":"297031","article-title":"An incidental finding of mucinous colon cancer by (18)F-choline PET\/CT determining a change in clinical management of a patient with recurrent prostate adenocarcinoma","volume":"2014","year":"2014","journal-title":"Case Rep Oncol Med"},{"key":"bib7-20230925","doi-asserted-by":"crossref","first-page":"e300","DOI":"10.1097\/RLU.0000000000001643","article-title":"18F-fluorocholine PET\/CT, brain MRI, and 5-aminolevulinic acid for the assessment of tumor resection in high-grade glioma","volume":"42","year":"2017","journal-title":"Clin Nucl Med"},{"key":"bib8-20230925","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1007\/s12149-018-1287-3","article-title":"Diagnostic performance of 11C-choline PET\/CT and FDG PET\/CT for staging and restaging of renal cell cancer","volume":"32","year":"2018","journal-title":"Ann Nucl Med"},{"key":"bib9-20230925","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/j.jhep.2018.02.018","article-title":"Positron emission tomography\/computed tomography with 18F-fluorocholine improve tumor staging and treatment allocation in patients with hepatocellular carcinoma","volume":"69","year":"2018","journal-title":"J Hepatol"},{"key":"bib10-20230925","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1097\/MOO.0b013e32835908ac","article-title":"Narrow band imaging in endoscopic evaluation of the larynx","volume":"20","year":"2012","journal-title":"Curr Opin Otolaryngol Head Neck Surg"},{"key":"bib11-20230925","year":"2018","journal-title":"Head and Neck Cancers NCCN Guidelines Version 2"},{"key":"bib12-20230925","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1007\/s00405-008-0901-8","article-title":"Endoscopic supraglottic laryngectomy: a proposal for a classification by the working committee on nomenclature, European Laryngological Society","volume":"266","year":"2009","journal-title":"Eur Arch Otorhinolaryngol"}],"container-title":["Clinical Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00003072-201907000-00031","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T13:37:54Z","timestamp":1785850674000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00003072-201907000-00031"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5,3]]},"references-count":12,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2019]]}},"URL":"https:\/\/doi.org\/10.1097\/rlu.0000000000002596","relation":{},"ISSN":["1536-0229","0363-9762"],"issn-type":[{"value":"1536-0229","type":"electronic"},{"value":"0363-9762","type":"print"}],"subject":[],"published":{"date-parts":[[2019,5,3]]}}}